251 Efficacy and safety of iparomlimab and tuvonralimab in previously treated patients with recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase 2 clinical trial (DUBHE-C-206)Hanmei Lou, Jihong Liu, Mingjun Zhang et al.|International Journal of Gynecological Cancer|2024Cited by 5
Incidence, risk factors, recovery duration, and prognostic implications of gastroparesis following radical distal gastrectomy for gastric cancer: a large retrospective cohort studyXue Han, Yingtai Chen, Lulu Zhao et al.|International Journal of Surgery|2026Cited by 0